(October 19, 2023, 12:01 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court should deny a petition for a writ of certiorari filed by the U.S. Food and Drug Administration and the manufacturer of the abortion drug mifepristone, in which it argues that an appellate court erred in finding that the FDA acted unlawfully in removing certain safety measures, but should the court decide to hear the case, then the justices must examine the entire FDA approval history of mifepristone, a group of anti-abortion advocates say in a conditional cross-petition for certiorari....